stanford school of medicine logotitle logo
advanced

 

 

Cardiology

 

Endocrinology

 

Gastroenterology

 

General Inpatient Medicine

 

Hematology

 

Infectious Disease

 

Nephrology

 

Neurology

 

Oncology

 

Outpatient & Preventative Medicine

 

Palliative Care

 

Psychiatry

 

Pulmonary/Critical Care

 

Rheumatology

Colon Cancer Syndromes (Hereditary)

Familial Adenomatous Polyposis (FAP)

  • < 1% of all cases of colon ca are 2/2 FAP
  • Autosomal dominant inheritance
  • Hundreds to thousands of adenomatous polyps, which develop in the teenage years and then progress to cancer between age 30 and 50
  • most often due to a germline mutation in the APC gene (5q21-q22), less commonly due to a biallelic mutation of the MYH gene (recessive pattern of transmission)
  • Mutations are detectable in 70% of patients (commercial testing available for APC and MYH)
  • Approx 95% of persons who meet the clinical criteria for a diagnosis of FAP will have an identifiable mutation in their APC gene
  • Approx 66% of those that have FAP have inherited a changed APC gene from a parent, whereas 33% are the first person in a family to have FAP
  • Most common location of cancer is in the periampullary region of the duodenum (b/c of this screening involves both colo and EGD)
  • Extracolonic manifestations include: benign (desmoids tumors, epidermoid and sebaceous cysts, gastic polys, mandibular osteomas, supernumerary teeth, congenital hypertrophy of the retinal pignement epithelium) and premalignant/malignant (small bowel adenomas and cancer, thyroid ca, gastric ca, CNS tumors, biliary ca)

 

Attenuated FAP

  • 10 to 100 polyps develop and the polyps and cancer occur about 10 yrs later than classic FAP
  • Similar gene mutations as FAP
  • Extracolonic manifestations can occur (as in FAP) if both APC and MYH genes affected

 

Hereditary Nonpolyposis Colorectal Ca (HNPCC)

  • Also known as Lynch syndrome
  • Autosomal dominant syndrome involving mismatch repair genes MLH1 and MLH2
  • Accelerated adenomaàcarcinoma sequence
  • 80% lifetime risk of colon ca, but generally develops after age 50
  • Associated with fewer than 10 polyps, cancers tend to occur on the R side of the colon with a mucinous pathology
  • Diagnosis is based on the Amsterdam II criteria (3-2-1 rule:3 relatives w associated cancer, 2 gnerations affected and 1 person diagnosed before age 50) or the Modified Bethesda Guidelines;
  • Extracolonic cancers: 40-60% lifetime risk of uterine ca and 10-12% risk of ovarian ca (also associated w cancers of the small bowel, stomach, pancreas and kidney/ureter)

 

Peutz-Jeghers Syndrome

  • Rare, autosomal dominant condition with polyps in the small bowel and colon; usually hamartomas,   although can undergo malignant transformation (80x increased risk for colon ca)
  • Germline mutation in STK11 gene
  • Classic perioral pigmentation
  • Extracolonic tumors include breast, pancreas, ovaries and lung

 

Juvenile Polyposis

  • Autosomal dominant condition with hamartomatous polyps, usually in the distal colon
  • Congenital manifestations of the GI tract, genitourinary system and hear
  • Germline mutation in the SMAD4 gene
  • Lifetime risk of colon ca is approx 70%
  •  

(Victoria Kelly MD, 8/31/10)